Literature DB >> 20153803

The nuclear isoform of the LIM domain protein Trip6 integrates activating and repressing signals at the promoter-bound glucocorticoid receptor.

Markus E Diefenbacher1, Margarethe Litfin, Peter Herrlich, Olivier Kassel.   

Abstract

Trip6 belongs to a family of cytosolic LIM domain proteins involved in cell adhesion and migration. Recent findings show that these proteins also regulate transcription. We have previously reported that nTrip6, a nuclear isoform of Trip6, acts as a co-activator for AP-1 and NF-kappaB transcription factors. Here we report that nTrip6 is an essential regulator of glucocorticoid receptor (GR) transcriptional activity. nTrip6 is recruited to GR-bound promoters through an interaction with GR, and increases GR-mediated transcription. nTrip6 is also essential for the transrepression of GR by NF-kappaB and AP-1. The interaction of nTrip6 with NF-kappaB and AP-1 at a GR-bound promoter is required for the repression. Thus, nTrip6 serves as the molecular mediator of the crosstalk between nuclear receptors and other transcription factors in that it assembles these factors at promoters. Our results reveal an essential role for LIM domain proteins in the integration of positive and negative signals at target promoters. (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153803     DOI: 10.1016/j.mce.2010.02.010

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

Review 1.  An emerging link between LIM domain proteins and nuclear receptors.

Authors:  Stefano Sala; Christophe Ampe
Journal:  Cell Mol Life Sci       Date:  2018-02-10       Impact factor: 9.261

Review 2.  Nuclear receptors in inflammation control: repression by GR and beyond.

Authors:  Yurii Chinenov; Rebecca Gupte; Inez Rogatsky
Journal:  Mol Cell Endocrinol       Date:  2013-04-26       Impact factor: 4.102

Review 3.  TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.

Authors:  Victor T G Lin; Fang-Tsyr Lin
Journal:  Cell Signal       Date:  2011-06-13       Impact factor: 4.315

Review 4.  There goes the neighborhood: Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor.

Authors:  Franziska Greulich; M Charlotte Hemmer; David A Rollins; Inez Rogatsky; N Henriette Uhlenhaut
Journal:  Steroids       Date:  2016-05-15       Impact factor: 2.668

5.  The LIM domain protein nTRIP6 modulates the dynamics of myogenic differentiation.

Authors:  Tannaz Norizadeh Abbariki; Zita Gonda; Denise Kemler; Pavel Urbanek; Tabea Wagner; Margarethe Litfin; Zhao-Qi Wang; Peter Herrlich; Olivier Kassel
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

6.  Hypothesis: Cryptochromes and Brown Fat are Essential for Adaptation and Affect Mood and Mood-Related Behaviors.

Authors:  Timo Partonen
Journal:  Front Neurol       Date:  2012-11-05       Impact factor: 4.003

7.  The LIM domain protein nTRIP6 recruits the mediator complex to AP-1-regulated promoters.

Authors:  Markus E Diefenbacher; Daniela Reich; Oliver Dahley; Denise Kemler; Margarethe Litfin; Peter Herrlich; Olivier Kassel
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

8.  Pubertal development in healthy children is mirrored by DNA methylation patterns in peripheral blood.

Authors:  Kristian Almstrup; Marie Lindhardt Johansen; Alexander S Busch; Casper P Hagen; John E Nielsen; Jørgen Holm Petersen; Anders Juul
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

9.  The LIM domain protein nTRIP6 acts as a co-repressor for the transcription factor MEF2C in myoblasts.

Authors:  Denise Kemler; Oliver Dahley; Sven Roßwag; Margarethe Litfin; Olivier Kassel
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

10.  Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode.

Authors:  Spiros A Vlahopoulos
Journal:  Cancer Biol Med       Date:  2017-08       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.